TrialBone marrow transplantation2017

Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL).

N Shah et al.PubMed ↗Publisher ↗

No numbers read from the abstract.